Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Howard

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Clinical Pharmacology and Therapeutics|July 1, 1995
Acetylcholinesterase inhibition by zifrosilone: pharmacokinetics and pharmacodynamicsN R Cutler, R D Seifert, M M Schleman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1997
Time course of 5-HT2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomographyG Gründer, F Yokoi, S J Offord, et al.
Mutagenesis|November 1, 1990
Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitroL C Backer, J W Allen, K Harrington-Brock, et al.
Medical and Pediatric Oncology|July 9, 1999
Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Lau, L C Ingram, et al.
Journal of Clinical Microbiology|April 1, 1996
Detection of Mycobacterium tuberculosis in respiratory specimens by strand displacement amplification of DNAJ A Down, M A O'Connell, M S Dey, et al.
Leukemia|February 21, 2017
Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLLT Munir, D R Howard, L McParland, et al.
Leukemia|March 25, 2017
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLLD R Howard, T Munir, L McParland, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Clinical Pharmacology and Therapeutics|July 1, 1995
Acetylcholinesterase inhibition by zifrosilone: pharmacokinetics and pharmacodynamicsN R Cutler, R D Seifert, M M Schleman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1997
Time course of 5-HT2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomographyG Gründer, F Yokoi, S J Offord, et al.
Mutagenesis|November 1, 1990
Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitroL C Backer, J W Allen, K Harrington-Brock, et al.
Medical and Pediatric Oncology|July 9, 1999
Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Lau, L C Ingram, et al.
Journal of Clinical Microbiology|April 1, 1996
Detection of Mycobacterium tuberculosis in respiratory specimens by strand displacement amplification of DNAJ A Down, M A O'Connell, M S Dey, et al.
Leukemia|February 21, 2017
Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLLT Munir, D R Howard, L McParland, et al.
Leukemia|March 25, 2017
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLLD R Howard, T Munir, L McParland, et al.
Pageof 9